Birth ControlReferencesCitationsHatcher RA, et al. (2005). Pocket
Guide to Managing Contraception 2005–2007. Tiger, GA: Bridging the Gap
Foundation. Brill SR, Rosenfeld WD (2000). Contraception.
Medical Clinics of North America, 84(4):
907–925. Minnis AM, Padian NS (2005). Effectiveness of female
controlled barrier methods in preventing sexually transmitted infections and
HIV: Current evidence and future research directions. Sexually
Transmitted Infections, 81(3): 193–200. Yonkers KA, et al. (2005). Efficacy of a new low-dose
oral contraceptive with drospirenone in premenstrual dysphoric disorder.
Obstetrics and Gynecology, 106(3): 492–501. Cheng D (2000). The intrauterine device: Still
misunderstood after all these years. Southern Medical
Journal, 93(9): 859–864. Grimes DA (2003). Contraception during breastfeeding.
The Contraception Report, 13(4): 7–13. Trussell J (2004). The essentials of contraception:
Efficacy, safety, and personal considerations. In RA Hatcher et al., eds.,
Contraceptive Technology, 18th ed., pp. 221–252. New
York: Ardent Media. American College of Obstetricians and Gynecologists
(2005). Intrauterine device. ACOG Practice Bulletin No. 59. Obstetrics and Gynecology, 105(1): 223–232. Morrison CS, et al. (2004). Hormonal contraceptive
use, cervical ectopy, and the acquisition of cervical infections.
Sexually Transmitted Diseases, 31(9):
561–567. U.S. Food and Drug Administration (2004). Black box
warning added concerning long-term use of Depo-Provera contraceptive injection.
FDA Talk Paper No. T04-50. Available online:
http://www.fda.gov/bbs/topics/ANSWERS/2004/ANS01325.html. Scholes D, et al. (2005). Change in bone mineral
density among adolescent women using and discontinuing depot
medroxyprogesterone acetate contraception. Archives of
Pediatrics and Adolescent Medicine, 159(2): 139–144. Davidson MR (2003). Contraception update: The latest
hormonal options. Clinician Reviews, 13(6):
52–59.
Other Works ConsultedBlack A, et al. (2004). Canadian contraception
consensus. SOGC Clinical Practice Guidelines No. 143, part 1 of 3.
Journal of Obstetrics and Gynaecology Canada, 26(2):
143–156. Black A, et al. (2004). Canadian contraception
consensus. SOGC Clinical Practice Guidelines No. 143, part 2 of 3.
Journal of Obstetrics and Gynaecology Canada, 26(3):
219–254. Black A, et al. (2004). Canadian contraception
consensus. SOGC Clinical Practice Guidelines No. 143, part 3 of 3.
Journal of Obstetrics and Gynaecology Canada, 26(4):
347–387. Davis VJ, Mykitiuk R (2001). The rights of the
adolescent: The mature minor. Journal of Obstetrics and
Gynaecology Canada, 23(4): 343–345. Grimes DA (2002). Switching emergency contraception to
over-the-counter status. New England Journal of
Medicine, 347(11): 846–849. Raymond E (2005). Emergency contraception. ACOG
Practice Bulletin No. 69. Obstetrics and Gynecology, 106(6):
1443–1452.
Go to previous section | Go to top of page | Go to next section |
| | Author: | Merrill Hayden Carrie Henley | Last Updated: August 16, 2006 | | Medical Review: | Adam Husney, MD - Family Medicine Joy Melnikow, MD, MPH - Family Medicine Kirtly Jones, MD - Obstetrics and Gynecology Femi Olatunbosun, MB, FRCSC - Obstetrics, Gynecology and Reproductive Medicine | © 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
| 
| |
| |